These findings are in line with the recognised pro-angiogenic properties of CCL2 [57, 58], and also with data from another study showing that CCL2 released by pituitary tumour-associated fibroblasts correlated with the PitNET microvessel area [10]. The gene discussed is CCL2; the disease is pituitary tumor.